Publication date: January 2027 Source: Journal of Vascular Surgery: Venous and Lymphatic Disorders, Volume 15, Issue 1 Author(s): Alessia L. Taylor, Oscar Moreno, Catherine E. Luke, Mattea Pellerito, Antonio Pellerito, Nehali Patel, Qing Cai, Sabrina Rocco, Daniel D. Myers, Thomas Wakefield, Andrea T. Obi, Peter Henke
Targeting α6β1 integrin signaling with pranlukast to modulate venous endothelium function and reduce post-thrombotic vein wall injury. // Journal of Vascular Surgery: Venous and Lymphatic Disorders. – URL: https://www.sciencedirect.com/science/article/pii/S2213333X26001757?dgcid=rss_sd_all
Targeting α6β1 integrin signaling with pranlukast to modulate venous endothelium function and reduce post-thrombotic vein wall injury. Journal of Vascular Surgery: Venous and Lymphatic Disorders. https://www.sciencedirect.com/science/article/pii/S2213333X26001757?dgcid=rss_sd_all
“Targeting α6β1 integrin signaling with pranlukast to modulate venous endothelium function and reduce post-thrombotic vein wall injury.” Journal of Vascular Surgery: Venous and Lymphatic Disorders.
@article{article31500,
title = {Targeting α6β1 integrin signaling with pranlukast to modulate venous endothelium function and reduce post-thrombotic vein wall injury},
journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
url = {https://www.sciencedirect.com/science/article/pii/S2213333X26001757?dgcid=rss_sd_all}
}